Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy

A. Fassas, I. Gojo, A. Rapoport, M. Cottler-Fox, B. Meisenberg, J. C. Papadimitriou, G. Tricot

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

We report on three patients with multiple myeloma who developed drug-induced pneumonitis 1-2 1/2 months following maintenance (post autologous transplantation) chemotherapy with CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) and 6-20 months after exposure to carmustine (BCNU) 300 mg/m2, used in combination with melphalan 140 mg/m2, as pre-transplant conditioning regimen. All patients had either a proven (two) or suspected (one) fungal pneumonia and were treated with liposomal amphotericin B. Dyspnea, fever and cough were the prominent clinical symptoms, while air-space disease with ground glass appearance was seen radiographically. Histologic features typical for drug-induced lung injury were detected. All patients had a dramatic, clinical and radiographic response to a brief course of corticosteroids. Although CDEP-induced pneumonitis appears to be a rare complication, its early recognition and prompt treatment, as well as its possible association with preceding fungal infection may have important clinical implications.

Original languageEnglish (US)
Pages (from-to)399-403
Number of pages5
JournalBone marrow transplantation
Volume28
Issue number4
DOIs
StatePublished - 2001
Externally publishedYes

Keywords

  • CDEP chemotherapy
  • Fungal infection
  • Non-infective pulmonary toxicity

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Fingerprint

Dive into the research topics of 'Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy'. Together they form a unique fingerprint.

Cite this